ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

China: Evergrande accused of inflating revenues by USD 78 billion

Chinese regulators have accused Evergrande and its founder of inflating revenues by USD 78 billion, putting the insolvent property developer at the heart of the country's biggest-ever financial fraud case, CNN reported.

ANI Mar 20, 2024 06:00 IST googleads

Representative Image

Beijing [China], March 20 (ANI): Chinese regulators have accused Evergrande and its founder of inflating revenues by USD 78 billion, putting the insolvent property developer at the heart of the country's biggest-ever financial fraud case, CNN reported.
The China Securities Regulatory Commission (CSRC) slapped a penalty of 4.175 billion yuan (USD 580 million) on Hengda Real Estate, the group's main Chinese unit, the company said in filings to the Shenzhen Stock Exchange on Monday.
Xu Jiayin, founder and chairman of the Evergrande Group, was fined 47 million yuan (USD 6.5 million) for the overstatement and other alleged violations. Jiayin , who was once China's richest man, was also barred from the securities markets for life.
The findings were revealed after an eight-month-long investigation by the CSRC, as reported by CNN.
The investigation had previously derailed Evergrande's debt restructuring talks with its overseas bondholders in the fall, because the company couldn't issue new notes, according to a company statement issued in September.
Days later, Evergrande said its chairman had been detained by Chinese authorities on suspicion of "crimes." In January 2024, a Hong Kong court ordered Evergrande to liquidate.
In Monday's filing, Hengda said the CSRC accused the company of several violations, including inflating sales in its financial reports, relying on these allegedly falsified figures to sell bonds and failing to disclose relevant information as required.
The regulator said Hengda had fabricated 214 billion yuan (USD 30 billion) in sales for 2019, which accounted for half of that year's revenue. Another 350 billion yuan (USD 48.6 billion) in sales for 2020, accounting for 78 per cent of revenue, were also falsified.
As a result, 2019's net profit was inflated by 63 per cent and 2020's net profit by 87 per cent, it said.
The alleged fraud, amounting to a total of 564.1 billion yuan (USD 78 billion) over two years, is the largest ever financial fraud case in mainland China's securities markets, according to previous regulatory statements and state media reports, according to CNN.
In addition to the penalties levied on Hengda and Xu, six other executives were fined by the CSRC for being "directly responsible."
Like Xu, Xia Haijun, the former vice chairman and CEO of Evergrande Group, was also banned from the nation's securities markets for life.
"Xu Jiayin had made decisions, organized, and implemented the financial fraud...Xia Haijun had organized, arranged and prepared the falsified financial reports...their means were really bad and the circumstances were grave," the regulator said. (ANI)

Get the App

What to Read Next

Europe

Growing empowerment of women reflects changing social landscape

Growing empowerment of women reflects changing social landscape

In her statement, Bhat said new pathways to empowerment are emerging across the Union Territory, supported by government initiatives and community participation.

Read More
Asia

China’s expanding system of censorship exposed in Dharamshala

China’s expanding system of censorship exposed in Dharamshala

The event titled "Understanding China's System of Political Repression: Voices of Resistance through Art and Journalism" brought together prominent voices critical of China's information control, as reported by Phayul.

Read More
Asia

Jaishankar, Indonesia’s FM exchange perspective on W Asia crisis

Jaishankar, Indonesia’s FM exchange perspective on W Asia crisis

In a post on X, Jaishankar wrote, "Pleased to talk to FM Sugiono of Indonesia. Exchanged perspectives on the West Asia conflict. Discussed bilateral ties and agreed to hold the Joint Commission meeting at an early date."

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Asia

Pakistan’s outdated mandi system stifles agricultural innovation

Pakistan’s outdated mandi system stifles agricultural innovation

Pakistan's fruit and vegetable supply remains dominated by traditional middlemen and the "mandi" system, with digital platforms handling only 2-3% of trade. Restrictive provincial laws and lack of infrastructure force farmers into dependency on commission agents, stalling modern technological transformation in the agricultural sector.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.